Literature DB >> 32414809

Tracing Self-Reactive B Cells in Normal Mice.

Takuya Nojima1, Alexander E Reynolds1, Daisuke Kitamura2, Garnett Kelsoe1,3, Masayuki Kuraoka4.   

Abstract

BCR transgenic mice dominate studies of B cell tolerance; consequently, tolerance in normal mice expressing diverse sets of autoreactive B cells is poorly characterized. We have used single B cell cultures to trace self-reactivity in BCR repertoires across the first and second tolerance checkpoints and in tolerized B cell compartments of normal mice. This approach reveals affinity "setpoints" that define each checkpoint and a subset of tolerized, autoreactive B cells that is long-lived. In normal mice, the numbers of B cells avidly specific for DNA fall significantly as small pre-B become immature and transitional-1 B cells, revealing the first tolerance checkpoint. By contrast, DNA reactivity does not significantly change when immature and transitional-1 B cells become mature follicular B cells, showing that the second checkpoint does not reduce DNA reactivity. In the spleen, autoreactivity was high in transitional-3 (T3) B cells, CD93+IgM-/loIgDhi anergic B cells, and a CD93- anergic subset. Whereas splenic T3 and CD93+ anergic B cells are short-lived, CD93-IgM-/loIgDhi B cells have half-lives comparable to mature follicular B cells. B cell-specific deletion of proapoptotic genes, Bak and Bax, resulted in increased CD93-IgM-/loIgDhi B cell numbers but not T3 B cell numbers, suggesting that apoptosis regulates differently persistent and ephemeral autoreactive B cells. The self-reactivity and longevity of CD93-IgM-/loIgDhi B cells and their capacity to proliferate and differentiate into plasmacytes in response to CD40 activation in vitro lead us to propose that this persistent, self-reactive compartment may be the origin of systemic autoimmunity and a potential target for vaccines to elicit protective Abs cross-reactive with self-antigens.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32414809      PMCID: PMC7311292          DOI: 10.4049/jimmunol.1901015

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

2.  Reaction patterns of monoclonal antibodies to DNA.

Authors:  R J Smeenk; K Brinkman; H G van den Brink; A A Westgeest
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.

Authors:  Goran Bajic; Max J Maron; Yu Adachi; Taishi Onodera; Kevin R McCarthy; Charles E McGee; Gregory D Sempowski; Yoshimasa Takahashi; Garnett Kelsoe; Masayuki Kuraoka; Aaron G Schmidt
Journal:  Cell Host Microbe       Date:  2019-05-16       Impact factor: 21.023

4.  Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.

Authors:  Akiko Watanabe; Kevin R McCarthy; Masayuki Kuraoka; Aaron G Schmidt; Yu Adachi; Taishi Onodera; Keisuke Tonouchi; Timothy M Caradonna; Goran Bajic; Shengli Song; Charles E McGee; Gregory D Sempowski; Feng Feng; Patricia Urick; Thomas B Kepler; Yoshimasa Takahashi; Stephen C Harrison; Garnett Kelsoe
Journal:  Cell       Date:  2019-05-16       Impact factor: 41.582

5.  Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

Authors:  Barton F Haynes; Judith Fleming; E William St Clair; Herman Katinger; Gabriela Stiegler; Renate Kunert; James Robinson; Richard M Scearce; Kelly Plonk; Herman F Staats; Thomas L Ortel; Hua-Xin Liao; S Munir Alam
Journal:  Science       Date:  2005-04-28       Impact factor: 47.728

6.  The human fetal lymphocyte lineage: identification by CD27 and LIN28B expression in B cell progenitors.

Authors:  Laurie McWilliams; Kuei-Ying Su; Xiaoe Liang; Dongmei Liao; Serina Floyd; Joshua Amos; M Anthony Moody; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Leukoc Biol       Date:  2013-07-30       Impact factor: 4.962

Review 7.  The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases.

Authors:  Eric Meffre
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

8.  Bruton's tyrosine kinase is essential for human B cell tolerance.

Authors:  Yen-Shing Ng; Hedda Wardemann; James Chelnis; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Exp Med       Date:  2004-10-04       Impact factor: 14.307

9.  Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.

Authors:  Goran Bajic; Cees E van der Poel; Masayuki Kuraoka; Aaron G Schmidt; Michael C Carroll; Garnett Kelsoe; Stephen C Harrison
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

10.  Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.

Authors:  Kevin R McCarthy; Akiko Watanabe; Masayuki Kuraoka; Khoi T Do; Charles E McGee; Gregory D Sempowski; Thomas B Kepler; Aaron G Schmidt; Garnett Kelsoe; Stephen C Harrison
Journal:  Immunity       Date:  2018-01-16       Impact factor: 43.474

View more
  3 in total

Review 1.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

2.  Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk.

Authors:  Jacqueline A Wright; Cassandra Bazile; Emily S Clark; Gianluca Carlesso; Justin Boucher; Eden Kleiman; Tamer Mahmoud; Lily I Cheng; Darlah M López-Rodríguez; Anne B Satterthwaite; Norman H Altman; Eric L Greidinger; Wasif N Khan
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

3.  Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancer.

Authors:  Alistair Noble; Edward T Pring; Lydia Durant; Ripple Man; Stella M Dilke; Lesley Hoyles; Steve A James; Simon R Carding; John T Jenkins; Stella C Knight
Journal:  Cancer Immunol Immunother       Date:  2022-03-22       Impact factor: 6.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.